Therefore, this study aimed to comprehensively characterize fluorescence kinetics, background clearance, and EGFR-dependent tumor uptake in colorectal cancer models to establish a solid preclinical foundation for colorectal-specific clinical translation of cetuximab-IRDye800CW. This evidence concerns the gene EGFR and colorectal cancer.